Should Flomax (Tamsulosin) and Terazosin Be Used Together?
No, Flomax (tamsulosin) and terazosin should not be used together for benign prostatic hyperplasia (BPH) or lower urinary tract symptoms (LUTS). Both medications are alpha-1 adrenergic blocking agents that work through the same mechanism, and combining them provides no additional therapeutic benefit while significantly increasing the risk of adverse effects, particularly hypotension and dizziness.
Why This Combination Is Not Recommended
Same Drug Class, Same Mechanism
- Both tamsulosin and terazosin are alpha-1 adrenergic antagonists that relax smooth muscle in the prostate and bladder neck 1
- The FDA drug label for Flomax explicitly warns that "interactions between FLOMAX capsules and other alpha adrenergic blocking agents may be expected" and states that the pharmacokinetic and pharmacodynamic interactions have not been determined 2
- Using two alpha blockers simultaneously does not provide additive benefit because they compete for the same receptor sites
Increased Risk of Adverse Effects
- Hypotension is the primary concern: Both drugs cause vasodilation and blood pressure lowering through alpha-1 blockade 2
- The FDA label specifically advises patients about "possible occurrence of symptoms related to postural hypotension, such as dizziness" with tamsulosin alone 2
- Combining two alpha blockers would amplify these cardiovascular effects without improving urinary symptoms
- Meta-analyses confirm that alpha-adrenergic blockers have vascular-related safety concerns 1
What the Evidence Actually Supports
Appropriate Combination Therapies for BPH/LUTS
Alpha Blocker + 5-Alpha Reductase Inhibitor:
- The 2023 European Association of Urology guidelines support combining tamsulosin with dutasteride or finasteride for men with enlarged prostates (>30-40cc) 1
- The CombAT study demonstrated 4-year efficacy of dutasteride plus tamsulosin combination therapy 1
Alpha Blocker + Antimuscarinic (for storage symptoms):
- When patients have persistent urgency and frequency despite alpha blocker therapy, adding an antimuscarinic like solifenacin or tolterodine is evidence-based 1
- The NEPTUNE trial showed efficacy and safety of solifenacin plus tamsulosin combination 1
- Meta-analysis confirms efficacy and safety of alpha blocker with anticholinergic combinations 1
Alpha Blocker + Beta-3 Agonist:
- Mirabegron add-on therapy to tamsulosin is supported by randomized controlled trials (MATCH and PLUS studies) for overactive bladder symptoms 1
Alpha Blocker + PDE5 Inhibitor:
- Tadalafil 5mg can be combined with tamsulosin for men with both LUTS/BPH and erectile dysfunction, though caution is needed due to potential hypotension 1, 3
- This combination shows better LUTS improvement than either monotherapy, with acceptable adverse event rates 3
The One Exception: Chronic Prostatitis Type III-B
- A single 2022 study examined tamsulosin plus terazosin specifically for chronic prostatitis Type III-B (not BPH) and reported improved symptom scores 4
- However, this indication is entirely different from BPH/LUTS, involved a small sample size (180 patients), and has not been replicated or validated in guidelines 4
- This does not justify dual alpha blocker use for standard BPH management
Clinical Bottom Line
For BPH/LUTS management, choose ONE alpha blocker as monotherapy. If symptoms persist despite adequate alpha blocker therapy:
- Add a 5-alpha reductase inhibitor (dutasteride or finasteride) if prostate is enlarged (>30-40cc) 1
- Add an antimuscarinic or mirabegron if storage symptoms (urgency, frequency) predominate 1
- Consider adding tadalafil 5mg if erectile dysfunction coexists 1, 3
Never combine two alpha blockers for BPH. The FDA label explicitly cautions against this approach, and no guideline supports it 2.